CoChat
Sign Up
Cited by 12,536Heart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 1,164 of the 1,170 references it cites were found in a registry or an index.

2013 ACCF/AHA Guideline for the Management of Heart Failure

Open access
Yancy, Clyde W., Jessup, Mariell, Bozkurt, Biykem, Butler, Javed, Casey, Donald E., Drazner, Mark H., Fonarow, Gregg C., Geraci, Stephen A., Horwich, Tamara, Januzzi, James L., Johnson, Maryl R., Kasper, Edward K., Levy, Wayne C., Masoudi, Frederick A., McBride, Patrick E., McMurray, John J.V., Mitchell, Judith E., Peterson, Pamela N., Riegel, Barbara, Sam, Flora, Stevenson, Lynne W., Tang, W.H. Wilson, Tsai, Emily J., Wilkoff, Bruce L.·2013·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2013.05.019
Open this paper in CoChat — free accountOpen PDF

Abstract

Introduction 1.1. Methodology and Evidence ReviewThe recommendations listed in this document are, whenever possible, evidence based.An extensive evidence review was conducted through October 2011 and includes selected other references through April 2013.Searches were extended to studies, reviews, and other evidence conducted in human subjects and that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected databases relevant to this guideline.Key search words included but were not limited to the following: heart failure, cardiomyopathy, quality of life, mortality, hospitalizations, prevention, biomarkers, hypertension, dyslipidemia, imaging, cardiac catheterization, endomyocardial biopsy, angiotensin-converting enzyme inhibitors, angiotensin-receptor antagonists/blockers, beta blockers, cardiac, cardiac resynchronization therapy, defibrillator, device-based therapy, implantable cardioverterdefibrillator, device implantation, medical therapy, acute decompensated heart failure, preserved ejection fraction, terminal care and transplantation, quality measures, and performance measures.Additionally, the committee reviewed documents related to the subject matter previously published by the ACCF and AHA.References selected and published in this document are representative and not all-inclusive.To provide clinicians with a representative evidence base, whenever deemed appropriate or when published, the absolute risk difference and number needed to treat or harm are provided in the guideline (within tables), along with confidence intervals and data related to the relative treatment effects such as odds ratio, relative risk, hazard ratio, and incidence rate ratio. Organization of the Writing CommitteeThe committee was composed of physicians and a nurse with broad expertise in the evaluation, care, and management of patients with heart failure (HF).The authors included general cardiologists, HF and transplant specialists, electrophysiologists, general internists, and physicians with methodological expertise.The committee included representatives from the ACCF, AHA, American Academy of Family Physicians, American College of Chest Physicians, American College of Physicians, Heart Rhythm Society, and International Society for Heart and Lung Transplantation. 1.3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.05.019

Cites

1164 of 1164 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Research works printed but not linked: 12

  1. Deleted in press.
  2. Epstein, 1977, Potentiation of furosemide by metolazone in refractory edema, Curr Ther Res, 656
  3. 1994, A randomized trial of beta-blockade in heart failure, Circulation, 90, 1765
  4. Deleted in press.
  5. Sharma, 2012, The utility of cardiac resynchronization therapy in patients with atrial fibrillation, J Innovations Cardiac Rhythm Manage, 621
  6. Deleted in press.
  7. Deleted in press.
  8. Deleted in press.
  9. Deleted in press.
  10. Deleted in press.
  11. Deleted in press.
  12. Deleted in press.

Cited by

Sorted by citations

See all 12,536

Related

See all

Metadata

Authors
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., Johnson, M. R., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., McMurray, J. J. V., Mitchell, J. E., Peterson, P. N., Riegel, B., Sam, F., Stevenson, L. W., Tang, W. H. W., Tsai, E. J., & Wilkoff, B. L.
Affiliations
  • American Heart Association (US)
  • American College of Chest Physicians (US)
  • International Society for Heart and Lung Transplantation (US)
  • American Academy of Family Physicians (US)
ORCID
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2013-10
Volume
62
Issue
16
Pages
e147-e239
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/j.jacc.2013.05.019
OpenAlex
W2119340816
Cited by
12,536
References
1,170
Citations by year
2026: 82 · 2025: 160 · 2024: 288 · 2023: 382 · 2022: 584 · 2021: 1176 · 2020: 1287 · 2019: 1220 · 2018: 1205 · 2017: 1305 · 2016: 1404 · 2015: 1308 · 2014: 1115 · 2013: 535
FWCI
989.27
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American College of Cardiology (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders
  • American Heart Association
  • American College of Cardiology Foundation
  • Heart Rhythm Society
  • University of Pennsylvania
  • State University of New York
  • Cleveland Clinic
  • St. Jude Medical
  • SUNY Downstate Medical Center
  • Biosense Webster
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
heart failure treatment, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, acute decompensated heart failure, implantable cardioverter-defibrillator, cardiac resynchronization therapy, beta-blockers, ACE inhibitors, angiotensin receptor blockers
MeSH terms
Adult, Heart Failure, Humans, United States, Disease Management, Evidence-Based Practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review